Role of the CXCR6/CXCL16 axis in autoimmune diseases-Reference-Cited by-同舟云学术

Role of the CXCR6/CXCL16 axis in autoimmune diseases

Published:2023-08 Issue: Volume:121 Page:110530
ISSN:1567-5769
Container-title:International Immunopharmacology
language:en
Short-container-title:International Immunopharmacology

Author:

Bao Nandi,Fu Bo,Zhong Xiaoling,Jia Shuangshuang,Ren Zhuangzhuang,Wang Haoran,Wang Weihua,Shi Hui,Li Jun,Ge Fulin,Chang Qing,Gong Yuan,Liu Wenhui,Qiu Feng,Xu Shiping,Li Tingting

Publisher

Elsevier BV

Subject

Pharmacology,Immunology,Immunology and Allergy

Reference157 articles.

1. Epigenetics underpinning the regulation of the CXC (ELR+) chemokines in non-small cell lung cancer;Baird;PLoS One,2011

2. Chemokines and chemokine receptors: positioning cells for host defense and immunity;Griffith;Annu. Rev. Immunol.,2014

3. The role of chemokines and chemokine receptors in multiple sclerosis;Cui;Int. Immunopharmacol.,2020

4. Chemokines in rheumatic diseases: pathogenic role and therapeutic implications;Miyabe;Nat. Rev. Rheumatol.,2019

5. Exploring the complex role of chemokines and chemoattractants in vivo on leukocyte dynamics;David;Immunol. Rev.,2019

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. 1,25-dihydroxyvitamin D3 augments low-dose PMA-based monocyte-to-macrophage differentiation in THP-1 cells;Journal of Immunological Methods;2024-09

2. Integration of single-cell and bulk RNA sequencing revealed immune heterogeneity and its association with disease activity in rheumatoid arthritis patients;Immunologic Research;2024-07-16

3. Natural killer cell memory: challenges and opportunities for cancer immunotherapy;Cancer Biology & Therapy;2024-07-10

4. Silencing CXCL16 alleviate neuroinflammation and M1 microglial polarization in mouse brain hemorrhage model and BV2 cell model through PI3K/AKT pathway;Experimental Brain Research;2024-06-19

5. RNA-Seq of an LPS-Induced Inflammation Model Reveals Transcriptional Profile Patterns of Inflammatory Processes;Life;2024-04-26